Patent directory · USPTO A61K / A61P
Patents matching “treatment”
2,520 pharma patents match "treatment" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 2,520 pharmaceutical patents matching "treatment" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 11110089
Pyridazinones and their use in the treatment of cancer
granted -
US 11110181
Virus-like particle conjugates for diagnosis and treatment of tumors
granted -
US 11111278
Use of a small native peptide activator of SERCA pump for treatment of heart failure and other disorders characterized by cytosolic calcium overload
granted -
US 11104719
Recombinant clusterin and use thereof in the treatment and prevention of disease
granted -
US 11103479
Small organic molecules for use in the treatment of neuroinflammatory disorders
granted -
US 11103491
Heterocyclic inhibitors of ERK1 and ERK2 and their use in the treatment of cancer
granted -
US 11103514
Treatment of muscular dystrophy
granted -
US 11104737
ACVR2A-specific antibody and method of treatment of muscle atrophy
granted -
US 11103504
Combination of a DNA condensation-inducing compound and an Eis inhibitor for antibiotic treatment
granted -
US 11098054
Englerin derivatives for treatment of cancer
granted -
US 11096910
Metabolically robust analogs of CYP-eicosanoids for the treatment of cardiac disease
granted -
US 11098103
CD80 extracellular domain polypeptides and their use in cancer treatment
granted -
US 11090285
Treatment of circadian rhythm disorders
granted -
US 11090293
Use of gaboxadol for the treatment of Tourette syndrome, tics and stuttering
granted -
US 11091473
Compounds for pain treatment, compositions comprising same, and methods of using same
granted -
US 11083799
Materials and methods for treatment of hereditary haemochromatosis
granted -
US 11083745
Antisense oligomers for treatment of autosomal dominant mental retardation-5 and Dravet Syndrome
granted -
US 11077078
Compositions and methods for the treatment of cancer
granted -
US 11078266
Anti-human IL-3 antibodies, their use in treatment of a disease or malfunction associated with elevated expression or levels of IL-3, and their use in a method to detect human IL-3
granted -
US 11077175
Compositions and methods for treatment of homocystinuria
granted -
US 11078242
Peptides for Covid-19 prevention and treatment
granted -
US 11078289
Cancer treatment
granted -
US 11072792
Materials and methods for treatment of usher syndrome type 2A
granted -
US 11072579
Treatment of cataplexy
granted